Symbiotec Pharmalab IPO Day 2: GMP Signals 34.41% Listing Gain; Check Subscription Status

As reported by NDTV Profit - Latest

Symbiotec Pharmalab IPO was fully subscribed on Day 2, with GMP signalling a 34.41% potential listing gain as investor demand remains strong.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

COMPANIES IPO fund diversion: Sebi bars Varanium Cloud, promoter for 7 years from markets Stocks-Markets-Economic Times
COMPANIES HEG demerger to take effect on September 1; record date fixed for September 7 Stocks-Markets-Economic Times
INDIAN US stocks today: US stocks open higher as tech stocks rebound before Nvidia results, data Markets-Economic Times
INDIAN Euro zone yields dip from multi-year highs as oil falls on Iran sanctions Markets-Economic Times
INDIAN Sterling hovers near six-month high underpinned by BoE rate hike expectations Markets-Economic Times
INDIAN UK gilt yields fall to lowest since mid-August as oil price slides Markets-Economic Times
INDIAN RBI net absorbed $561 million in June as inflows picked up Markets-Economic Times
INDIAN Fortune expands its mustard oil portfolio with launch of Yellow Mustard Oil Share Market Today

Symbiotec Pharmalab IPO Day 2: GMP Signals 34.41% Listing Gain; Check Subscription Status

More from Market Samachar